ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 04 Oct 2021
Last Applicant/ Owned by
One Johnson & Johnson Plaza
New Brunswick
NJ
08933
Serial Number
87790282 filed on 08th Feb 2018
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
DARSPONDA
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory dis Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Mark Details
Serial Number
No 87790282
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T36103US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Oct 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 04th Oct 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 09th Mar 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Mar 2021 | EXTENSION 5 GRANTED |
| 01st Mar 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 12th Feb 2021 | EXTENSION 5 FILED |
| 12th Feb 2021 | TEAS EXTENSION RECEIVED |
| 13th Aug 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th Aug 2020 | EXTENSION 4 FILED |
| 11th Aug 2020 | EXTENSION 4 GRANTED |